Видео ютуба по тегу Setuksimab

Cetuximab use for HNSCC
Cetuximab use for HNSCC
Clinical Development of Cetuximab in Metastatic Colorectal Cancer
Clinical Development of Cetuximab in Metastatic Colorectal Cancer
Cetuximab or Chemotherapy in HNSCC?
Cetuximab or Chemotherapy in HNSCC?
Dr. Vokes on Cetuximab for Head and Neck Cancer
Dr. Vokes on Cetuximab for Head and Neck Cancer
Cetuximab Safety Profile in Head and Neck Cancer
Cetuximab Safety Profile in Head and Neck Cancer
Upfront Bevacizumab and Cetuximab Compared in Metastatic Colorectal Cancer
Upfront Bevacizumab and Cetuximab Compared in Metastatic Colorectal Cancer
Dr. Weinberg on the Role of Cetuximab in Metastatic CRC
Dr. Weinberg on the Role of Cetuximab in Metastatic CRC
1L FOLFOXIRI plus cetuximab or bevacizumab for RAS wild-type mCRC
1L FOLFOXIRI plus cetuximab or bevacizumab for RAS wild-type mCRC
Dr. Benson on Sequencing Strategies with Cetuximab in CRC
Dr. Benson on Sequencing Strategies with Cetuximab in CRC
Afatinib Plus Cetuximab in Resistant Non-Small Cell Lung Cancer
Afatinib Plus Cetuximab in Resistant Non-Small Cell Lung Cancer
Dr. Ciccolini on Residual Concentrations of Cetuximab in Head and Neck Cancer
Dr. Ciccolini on Residual Concentrations of Cetuximab in Head and Neck Cancer
Dr. Janjigian Discusses Afatinib and Cetuximab for Patients With EGFR-Mutant Lung Cancer
Dr. Janjigian Discusses Afatinib and Cetuximab for Patients With EGFR-Mutant Lung Cancer
ASCO 2008: Cetuximab for metastatic colorectal cancer (mCRC)
ASCO 2008: Cetuximab for metastatic colorectal cancer (mCRC)
DEEPER: m-FOLFOXIRI and cetuximab versus bevacizumab in mCRC
DEEPER: m-FOLFOXIRI and cetuximab versus bevacizumab in mCRC
Stefan Kasper, MD, explains the dosing and administration schedule of cetuximab
Stefan Kasper, MD, explains the dosing and administration schedule of cetuximab
Dr. Bekaii-Saab Discusses an Analysis of Bevacizumab or Cetuximab for CRC
Dr. Bekaii-Saab Discusses an Analysis of Bevacizumab or Cetuximab for CRC
Bevacizumab and cetuximab (plus chemotherapy) equally effective for colorectal cancer patients
Bevacizumab and cetuximab (plus chemotherapy) equally effective for colorectal cancer patients
Cetuximab in Advanced HPV-Positive HNC
Cetuximab in Advanced HPV-Positive HNC
Cancer: Cetuximab (Erbitux)
Cancer: Cetuximab (Erbitux)